A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment
This study has been completed.
First Posted: June 23, 2008
Last Update Posted: January 22, 2014
Tibotec Pharmaceutical Limited
Information provided by (Responsible Party):